We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
The European Medicines Agency is asking for feedback on a revised guideline for the treatment of Alzheimer’s disease and other types of dementia. Read More
Merck & Co. is suing German biotech and chemical giant Merck KGaA in federal court for alleged trademark infringement as part of a larger battle between the two companies over the rights to the Merck name. Read More
Regulators around the world are joining forces as part of an investigation into why a patient died after being treated in a Phase 1 clinical study conducted by Biotrial, a French clinical research organization. Read More
The FDA repeatedly blasted overseas drugmakers last year for disregarding compliance orders and not living up to their own promises to carry out proper cGMP practices for active pharmaceutical ingredients. Read More
Citing a “detrimental effect on survival,” the FDA has placed a full clinical hold on the IND for CTI BioPharma’s myelofibrosis candidate pacritinib. Read More